Study of a new CAIX-targeting radiotracer, [99mTc]PHC-102, for SPECT imaging in ccRCC patients May 10, 2021 No Comments
Pivotal study evaluates PD-G-506-A for margin assessment during breast conserving surgery May 7, 2021 No Comments
FDA clears IND for phase I/II study of Clarity's prostate cancer theranostic products May 5, 2021 No Comments
Initiation of NOBLE Registry for Telix's TLX599-CDx SPECT in prostate cancer April 21, 2021 No Comments
[68Ga]NOTA-AE-105 PET/MRI useful for prostate cancer evaluation and reduces biopsy needs March 5, 2021 No Comments
Phase II trial of imaging agent [64Cu]SARTATE enrolls patients with known or suspected NETs Feb. 19, 2021 No Comments
TLX-591-CDx for prostate cancer imaging receives first E.U. approval in Czech Republic Feb. 16, 2021 No Comments
AC Immune begins first-in-human study of ACI-12589 as diagnostic for Parkinson's disease Feb. 10, 2021 No Comments